Registration Options

Activity Dates: 09/04/2020 - 09/04/2021

Target Audience

Physicians, pharmacists, nurse practitioners, and nurses treating patients with LAIs in the time of COVID-19.

Session Summary

The rapid onset of COVID-19 in the United States, combined with the dismantling of the spring 2020 medical conference infrastructure and widespread travel bans and social distancing has created a synchronous need in all clinical arenas to manage patients with pre-existing conditions, such as schizophrenia, who require management with LAIs. Join our expert faculty for this on-demand online activity, focusing on their expert insights into guiding patients, caregivers, and clinicians on using LAIs during the global health pandemic of COVID-19.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Complete the pre-test before starting the activity. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluationUpon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Christoph U. Correll, MD (Activity Chair)
Leigh Anne Nelson, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Outline current and emerging pharmacotherapy treatment options for schizophrenia, including mechanisms of action and formulations.
  2. Identify gaps in the current schizophrenia treatment paradigm, given the challenges of COVID-19, and give suggestions for increasing intervals of dosing and how to handle missed injections.

Continuing Education Credit and Disclosures

Activity Dates: 09/04/2020 - 09/04/2021
ACPE Contact Hours: 0.5
ACPE Number: 0284-9999-20-064-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Grant Support

This activity is supported by an educational grant from Alkermes.
This activity has been developed by Creative Educational Concepts, Inc. in partnership with the College of Psychiatric and Neurologic Pharmacists (CPNP) as the accredited provider.